Somnogenic relationships between tumor necrosis factor and interleukin-1.
Level 5 - mechanism / opinion, no new human data
Animal research (in vivo rabbit model)
PubMed 10198395 · doi:10.1152/ajpregu.1999.276.4.R1132
What was done
Researchers evaluated whether tumor necrosis factor (TNF) and interleukin-1 (IL-1) interact to regulate sleep in rabbits. They administered intracerebroventricular injections of a TNF receptor fragment (TNFRF), an IL-1 receptor fragment (IL-1RF), or their combination to assess effects on spontaneous sleep, sleep rebound following sleep deprivation, IL-1-induced sleep/fever, and TNF-induced sleep/fever.
What was found
Intracerebroventricular injection of the combination of TNFRF plus IL-1RF significantly reduced spontaneous non-rapid eye movement (NREM) sleep by 87 minutes over a 22-hour recording period. Pretreatment with the combined receptor fragments also significantly attenuated sleep rebound after sleep deprivation. Additionally, TNFRF significantly attenuated IL-1-induced sleep without altering fever, and IL-1RF blocked TNF-induced sleep responses without altering fever.
Why it matters
These findings show that TNF and IL-1 act interdependently to mediate physiological NREM sleep and homeostatic sleep rebound, separating their somnogenic signaling mechanisms from their pyrogenic actions.
Limits
The study was conducted entirely in rabbits, so findings cannot be directly assumed to reflect human sleep physiology. The abstract does not report the total sample size, baseline sleep durations, confidence intervals, or specific statistical test values.
Cited by
- supports Injecting pro-inflammatory cytokines into animals induces sleep.